214 related articles for article (PubMed ID: 1619503)
1. Potassium as a link between insulin and the renin-angiotensin-aldosterone system.
Ferrannini E; Galvan AQ; Santoro D; Natali A
J Hypertens Suppl; 1992 Apr; 10(1):S5-10. PubMed ID: 1619503
[TBL] [Abstract][Full Text] [Related]
2. Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition.
Ferrannini E; Seghieri G; Muscelli E
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S61-9. PubMed ID: 7700069
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.
Santoro D; Natali A; Palombo C; Brandi LS; Piatti M; Ghione S; Ferrannini E
Hypertension; 1992 Aug; 20(2):181-91. PubMed ID: 1639459
[TBL] [Abstract][Full Text] [Related]
4. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS
Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
[TBL] [Abstract][Full Text] [Related]
5. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
[TBL] [Abstract][Full Text] [Related]
6. Control of blood pressure by the renin-angiotensin-aldosterone system.
Hall JE
Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV6-21; discussion IV51-5. PubMed ID: 1893644
[TBL] [Abstract][Full Text] [Related]
7. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
Stephan D; Grima M; Welsch M; Barthelmebs M; Vasmant D; Imbs J
Fundam Clin Pharmacol; 1996; 10(5):474-83. PubMed ID: 8902551
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus, the renin-angiotensin system, and angiotensin-converting enzyme inhibition.
Björck S; Aurell M
Nephron; 1990; 55 Suppl 1():10-20. PubMed ID: 2189073
[TBL] [Abstract][Full Text] [Related]
9. Renovascular hypertension and insulin sensitivity.
Natali A; Quiñones Galvan A; Arzilli F; Taddei S; Pecori N; Frascerra S; Salvetti A; Ferrannini E
Eur J Clin Invest; 1996 Jul; 26(7):556-63. PubMed ID: 8864417
[TBL] [Abstract][Full Text] [Related]
10. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
Schalekamp MA; Derkx FH; van den Meiracker AH
J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Perkins JM; Davis SN
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
[TBL] [Abstract][Full Text] [Related]
14. [Relations between blood insulin concentration, renin-angiotensin-aldosterone system and clinical picture of hypertension].
Didenko VA; Simonov DV
Ter Arkh; 1999; 71(1):26-31. PubMed ID: 10097296
[TBL] [Abstract][Full Text] [Related]
15. Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension.
Sullivan PA; Kelleher M; Twomey M; Dineen M
J Hypertens; 1985 Aug; 3(4):359-63. PubMed ID: 2995484
[TBL] [Abstract][Full Text] [Related]
16. Studies on acute glucose-induced aldosterone suppression: role of renin-angiotensin system.
Nützi D; Beretta-Piccoli C; Ferrier CP; Link L; Gerber A; Weidmann P
Klin Wochenschr; 1984 Mar; 62(5):213-7. PubMed ID: 6371371
[TBL] [Abstract][Full Text] [Related]
17. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
[TBL] [Abstract][Full Text] [Related]
18. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
Stumpe KO
Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined therapy with amiloride and hydrochlorothiazide on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in hypertensive patients.
Svendsen UG; Ibsen H; Rasmussen S; Leth A; Nielsen MD; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1986; 30(2):151-6. PubMed ID: 3519243
[TBL] [Abstract][Full Text] [Related]
20. Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors/AT1 blockers.
Spannella F; Giulietti F; Balietti P; Borioni E; Lombardi FE; Ricci M; Cocci G; Landi L; Sarzani R
J Hypertens; 2017 Nov; 35(11):2315-2322. PubMed ID: 28614094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
